Juan He

725 total citations
33 papers, 494 citations indexed

About

Juan He is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juan He has authored 33 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juan He's work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (9 papers) and Ferroptosis and cancer prognosis (9 papers). Juan He is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (9 papers) and Ferroptosis and cancer prognosis (9 papers). Juan He collaborates with scholars based in China, Canada and Macao. Juan He's co-authors include Xinke Wang, Qingyuan Li, Side Liu, Qun Yan, Yuxin Fang, Chun-Cai Gu, Qiuhua Lai, Zhixian Lan, Yongfeng Liu and Yue Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Gene.

In The Last Decade

Juan He

31 papers receiving 491 citations

Peers

Juan He
Juan He
Citations per year, relative to Juan He Juan He (= 1×) peers Qinliang Fang

Countries citing papers authored by Juan He

Since Specialization
Citations

This map shows the geographic impact of Juan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan He more than expected).

Fields of papers citing papers by Juan He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan He. The network helps show where Juan He may publish in the future.

Co-authorship network of co-authors of Juan He

This figure shows the co-authorship network connecting the top 25 collaborators of Juan He. A scholar is included among the top collaborators of Juan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan He. Juan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Li, et al.. (2025). Analysis and validation of serum biomarkers in brucellosis patients through proteomics and bioinformatics. Frontiers in Cellular and Infection Microbiology. 14. 1446339–1446339. 4 indexed citations
2.
Song, Chang W., Yu‐Yan Pang, Bin Li, et al.. (2025). Molecular mechanisms of thymopoietin in papillary thyroid cancer: Multiplatform gene expression data, gene knockout screening, and in-house immunohistochemistry. World Journal of Clinical Oncology. 16(7). 107109–107109. 1 indexed citations
3.
He, Suisui, et al.. (2025). Rhodium-based metallodrugs for biological applications: current status and future perspectives. Materials Today Bio. 33. 101941–101941.
4.
Sun, Liangliang, et al.. (2024). Siglec15 in blood system diseases: from bench to bedside. Frontiers in Immunology. 15. 1490505–1490505.
5.
Luo, Chunyuan, Juan He, Yang Yang, et al.. (2024). SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression. Journal of Cancer Research and Clinical Oncology. 150(6). 292–292. 3 indexed citations
6.
Huang, Zhi‐Guang, Juan He, Lin Shi, et al.. (2024). Comprehensive transcriptome and scRNA‐seq analyses uncover the expression and underlying mechanism of SYNJ2 in papillary thyroid carcinoma. IET Systems Biology. 18(5). 183–198. 1 indexed citations
7.
Zhang, Lu, Rong‐Quan He, Zhi‐Guang Huang, et al.. (2024). Multiple Machine Learning Models, Molecular Subtyping and Singlecell Analysis Identify PANoptosis-related Core Genes and their Association with Subtypes in Crohn’s Disease. Current Medicinal Chemistry. 32(42). 9707–9740. 3 indexed citations
8.
Liu, Jialin, Xiu‐Fang Du, Juan He, et al.. (2023). High expression of centromere protein A and its molecular mechanism and clinical significance in prostate cancer: A study based on data mining and immunohistochemistry. IET Systems Biology. 17(5). 245–258. 3 indexed citations
9.
Huang, Zhi‐Guang, et al.. (2023). Nitidine chloride regulates cell function of bladder cancer in vitro through downregulating Lymphocyte antigen 75. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(9). 2071–2085. 2 indexed citations
10.
Chen, Gang, et al.. (2022). Downregulated miR-150-5p in the Tissue of Nasopharyngeal Carcinoma. Genetics Research. 2022. 1–13. 1 indexed citations
11.
Huang, Zhi‐Guang, et al.. (2022). Clinical value and potential mechanisms of BUB1B up-regulation in nasopharyngeal carcinoma. BMC Medical Genomics. 15(1). 272–272. 3 indexed citations
12.
Zeng, Peng, Xiaoyun Lu, Yingmei Peng, et al.. (2022). Thirteen Dipterocarpoideae genomes provide insights into their evolution and borneol biosynthesis. Plant Communications. 3(6). 100464–100464. 15 indexed citations
13.
Li, Guosheng, Rong‐Quan He, Jun Liu, et al.. (2022). Prognostic signature of esophageal adenocarcinoma based on pyroptosis-related genes. BMC Medical Genomics. 15(1). 50–50. 2 indexed citations
14.
Huang, Wan‐Ying, Gang Chen, Shangwei Chen, et al.. (2021). The Indication of Poor Prognosis by High Expression of ENO1 in Squamous Cell Carcinoma of the Lung. Journal of Oncology. 2021. 1–11. 6 indexed citations
15.
Li, Guosheng, Linjie Yang, Gang Chen, et al.. (2021). Laryngeal Squamous Cell Carcinoma: Clinical Significance and Potential Mechanism of Cell Division Cycle 45. Cancer Biotherapy and Radiopharmaceuticals. 37(4). 300–312. 6 indexed citations
16.
Gao, Li, Guosheng Li, Jian‐Di Li, et al.. (2021). Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods. Computational and Structural Biotechnology Journal. 19. 6229–6239. 15 indexed citations
17.
Huang, Lin, Jinling Liao, Juan He, et al.. (2020). Single-cell profiling reveals sex diversity in human renal proximal tubules. Gene. 752. 144790–144790. 12 indexed citations
18.
Gu, Chun-Cai, Jianqun Cai, Zhijun Xu, et al.. (2019). MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling. Cell Death and Disease. 10(10). 739–739. 83 indexed citations
19.
Wang, Xinke, Zhixian Lan, Juan He, et al.. (2019). LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells. Cancer Cell International. 19(1). 234–234. 88 indexed citations
20.
Fang, Ying, et al.. (2018). Peroxiredoxin 1, restraining cell migration and invasion, is involved in hepatocellular carcinoma recurrence. Journal of Digestive Diseases. 19(3). 155–169. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026